Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.

MLA

Ahmadi Bidakhvidi, Niloefar, et al. “Parameters Predicting [18F]PSMA-1007 Scan Positivity and Type and Number of Detected Lesions in Patients with Biochemical Recurrence of Prostate Cancer.” EJNMMI Research, vol. 11, no. 1, Apr. 2021, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13550-021-00783-w.

APA

Ahmadi Bidakhvidi, N., Laenen, A., Jentjens, S., Deroose, C. M., Van Laere, K., De Wever, L., Mai, C., Berghen, C., De Meerleer, G., Haustermans, K., Joniau, S., Everaerts, W., & Goffin, K. (2021). Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer. EJNMMI Research, 11(1), 1–10. https://doi.org/10.1186/s13550-021-00783-w

Chicago

Ahmadi Bidakhvidi, Niloefar, Annouschka Laenen, Sander Jentjens, Christophe M. Deroose, Koen Van Laere, Liesbeth De Wever, Cindy Mai, et al. 2021. “Parameters Predicting [18F]PSMA-1007 Scan Positivity and Type and Number of Detected Lesions in Patients with Biochemical Recurrence of Prostate Cancer.” EJNMMI Research 11 (1): 1–10. doi:10.1186/s13550-021-00783-w.